KA-1874

N/A

Report date: 2023/07/07 18:22:26

Base Information

Drug NameKA-1874
Drug Alias NameKA-1874
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-T cell immunoglobulin and ITIM domainsTransmembrane protein PVRIG antagonists
TargetsT cell immunoglobulin and ITIM domainsTransmembrane protein PVRIG
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesKYinno Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKYinno Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A